1,795
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants

, , , , , , , , , & show all
Pages 120-127 | Received 02 Jun 2016, Accepted 09 Aug 2016, Published online: 21 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Timo Vesikari, Luis Rivera, Tiina Korhonen, Anitta Ahonen, Brigitte Cheuvart, Marjan Hezareh, Winnie Janssens & Narcisa Mesaros. (2017) Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa. Human Vaccines & Immunotherapeutics 13:7, pages 1505-1515.
Read now

Articles from other publishers (5)

Michael D. Decker, Barbara J. Howe, David P. Greenberg & Kathryn M. Edwards. 2023. Plotkin's Vaccines. Plotkin's Vaccines 225 247.e13 .
Ivneet Kour, Lipika Singhal & Varsha Gupta. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research 749 759 .
Nawarat Posuwan, Nasamon Wanlapakorn, Sompong Vongpunsawad, Palittiya Sintusek, Elke Leuridan, Pierre Van Damme & Yong Poovorawan. (2020) Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth. Vaccine 38:7, pages 1643-1651.
Crossref
Amar Jeet Chitkara, Raunak Parikh, Attila Mihalyi & Shafi Kolhapure. (2019) Hexavalent Vaccines in India: Current Status. Indian Pediatrics 56:11, pages 939-950.
Crossref
Lalitendu Mohanty, Sunil Sharma, Beauty Behera, Sachin Panwar, Charu Paliwal, Anu Gupta, Deepak Chandra Chilkoti & Anit Singh. (2018) A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants. Vaccine 36:17, pages 2378-2384.
Crossref